Do you offer adjuvant androgen deprivation therapy for AR+ salivary ductal carcinomas treated with curative intent?

There is a recently released ASCO guideline [Geiger et al., PMID 33900808] which specifically addresses the role of systemic therapy in the management of salivary gland malignancies.

Regarding systemic therapy, the recent ASCO guideline suggests concurrent chemotherapy, HER2-Neu targeted therapies, a...